Vegrandis, LLC

VEGRANDIS, LLC, 535 W. Research Blvd., Suite 135, M/S 200
Fayetteville, AR 72701

SBIR Award Summary

Total Number of Awards 16
Total Value of Awards $4.02MM
First Award Date 01/01/03
Most Recent Award Date 07/10/10

Key Personnel

Last Name Name Awards Contact
Fritsch Ingrid Fritsch 2 Message
Wansapura Chamika Wansapura 5 Message
Aguilar Zoraida Pascual Aguilar 9 Message
Wagstaff Mark Wagstaff 8 Message
Goforth Calvin Goforth 1 Message

16 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-114
Budget: 07/10/10 - 06/30/12

DESCRIPTION (provided by applicant): The main goal of this Phase I SBIR project is to demonstrate the feasibility of using a novel carbon-based nanopipette (CNP) for precise and controlled microinjection of macromolecules into single cells and allow electrical measurement of variations in membrane potential upon penetrating a cell. The ultimate ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 08/01/09 - 01/31/11

DESCRIPTION (provided by applicant): The main goal of this Phase I SBIR project is to optimize the fabrication process and demonstrate the feasibility of using a novel carbon-based nanopipette (CNP electroprobe) for penetration of cell membrane in single cells with minimal cell intrusion and allow measurement of changes in potential or ionic cur...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 03/13/09 - 09/12/10

DESCRIPTION (provided by applicant): Vegrandis proposes to develop a rapid, sensitive, high throughput, inexpensive, and easy to use system for the ante-mortem diagnosis of prion infection. The proposed system offers a fully automated equipment with a disposable microelectrochemical cartridge for diagnosis of ante- mortem levels as low as 1 x 10...

Phase 1 STTR

Institution: University of Pennsylvania

Agency: National Science Foundation
Topic: 2007
Budget: 01/01/07 - 12/31/07

This Small Business Technology Transfer (STTR) Phase I project is to develop a novel and commercially scalable method for fabricating integrated carbon nanopipes (nanopipettes). The carbon nanopipettes (CNP) have a wide variety of potential applications both for liquid delivery and as nanoelectrodes for electrochemical detection. The patent pend...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/06 - 04/30/09

DESCRIPTION (provided by applicant): In this Phase II project, Vegrandis, LLC proposes to develop a magnetohydrodynamic (MHD) microfluidic based "sample-in, answer-out" bioassay chip for diagnosis of ovarian cancer. The proposed bioassay chip will use MHD microfluidics to pump the sample and reagents necessary to perform the assay and will have ...

Phase 2 SBIR

Agency: Environmental Protection Agency
Topic: 2006
Budget: 01/01/06 - 12/31/06

Cryptosoridium is a resilient waterborne protozoan pathogen that caused gastrointestinal disease and is one of five major causes for 5 million deaths each year worldwide. Recently, a Cryptosoridium outbreak has sickened more than 1,700 people, mostly children and teenagers in New York. Cryptosoridium oocysts are of particular interest in the w...

Phase 2 SBIR

Agency: National Science Foundation
Topic: 2006
Budget: 01/01/06 - 12/31/06

This Small Business Innovation Research (SBIR) Phase II project focuses on the development of an automated, high-throughput, sensitive and specific assay for the micorelectrochemical detection of malaria parasites. The use of microelectrochemical assay will allow for the detection of malarial parasites with a combination of attributes, such as a...

Phase 1 STTR

Institution: University of Arkansas

Agency: National Science Foundation
Topic: 2006
Budget: 01/01/06 - 12/31/06

This Small Business Technology Transfer (STTR) Phase I project will develop a self-contained microelectrochemical assay array for simultaneous and quantitative detection of allergens in dust such as dust mites, cat dander, and cockroach allergens. Allergies cause illness and disabilities that affect over 50 million Americans. Avoidance or reduct...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/22/05 - 08/31/06

DESCRIPTION (provided by applicant): In this Phase II project, Vegrandis, LLC proposes to develop a magnetohydrodynamic (MHD) microfluidic based "sample-in, answer-out" bioassay chip for diagnosis of ovarian cancer. The proposed bioassay chip will use MHD microfluidics to pump the sample and reagents necessary to perform the assay and will have ...

Phase 2 SBIR

Agency: National Science Foundation
Topic: 2005
Budget: 01/01/05 - 12/31/05

This Small Business Innovation Research (SBIR) Phase II project aims to develop an automated instrument for rapid and specific detection of waterborne pathogens in municipal water supplies using methods combining immunoassay with electrochemistry. Although the disposable cartridges for this instrument could be specified for nearly any pathogen ...

Load More